(19)
(11) EP 2 585 075 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
22.09.2021 Bulletin 2021/38

(45) Mention of the grant of the patent:
18.08.2021 Bulletin 2021/33

(21) Application number: 11799004.4

(22) Date of filing: 24.06.2011
(51) International Patent Classification (IPC): 
A61K 31/58(2006.01)
A61K 31/575(2006.01)
A61K 31/16(2006.01)
A61P 29/00(2006.01)
A61K 47/36(2006.01)
A61K 31/573(2006.01)
A61K 9/14(2006.01)
A61K 9/00(2006.01)
A61P 1/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 29/00; A61K 9/0095; A61K 31/575; A61K 47/36; A61P 1/00; A61K 31/573; A61K 31/58
(86) International application number:
PCT/US2011/041871
(87) International publication number:
WO 2011/163614 (29.12.2011 Gazette 2011/52)

(54)

METHODS OF TREATMENT FOR ESOPHAGEAL INFLAMMATION

BEHANDLUNGSVERFAHREN FÜR SPEISERÖHRENENTZÜNDUNGEN

MÉTHODES DE TRAITEMENT DE L'INFLAMMATION OESOPHAGIENNE


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 24.06.2010 US 358401 P
06.05.2011 US 201161483580 P
28.06.2010 US 359311 P
24.11.2010 US 417085 P

(43) Date of publication of application:
01.05.2013 Bulletin 2013/18

(60) Divisional application:
21191684.6

(73) Proprietor: ViroPharma Biologics LLC
Lexington, MA 02421 (US)

(72) Inventors:
  • PHILLIPS, Elaine
    San Diego, CA 92130 (US)
  • HILL, Malcolm
    San Diego, CA 92130 (US)

(74) Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)


(56) References cited: : 
WO-A2-2009/132048
US-A1- 2009 123 550
US-A1- 2009 181 099
US-A1- 2011 081 411
WO-A2-2009/132048
US-A1- 2009 123 550
US-A1- 2009 181 099
   
  • None
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).